| Literature DB >> 25024429 |
Ken Igawa1, Chikara Kokubu2, Kosuke Yusa2, Kyoji Horie2, Yasuhide Yoshimura2, Kaori Yamauchi2, Hirofumi Suemori2, Hiroo Yokozeki2, Masashi Toyoda2, Nobutaka Kiyokawa2, Hajime Okita2, Yoshitaka Miyagawa2, Hidenori Akutsu2, Akihiro Umezawa2, Ichiro Katayama2, Junji Takeda1.
Abstract
Human induced pluripotent stem cell (hiPSC) lines have a great potential for therapeutics because customized cells and organs can be induced from such cells. Assessment of the residual reprogramming factors after the generation of hiPSC lines is required, but an ideal system has been lacking. Here, we generated hiPSC lines from normal human dermal fibroblasts with piggyBac transposon bearing reprogramming transgenes followed by removal of the transposon by the transposase. Under this condition, we compared the phenotypes of transgene-residual and -free hiPSCs of the same genetic background. The transgene-residual hiPSCs, in which the transcription levels of the reprogramming transgenes were eventually suppressed, were quite similar to the transgene-free hiPSCs in a pluripotent state. However, after differentiation into keratinocytes, clear differences were observed. Morphological, functional, and molecular analyses including single-cell gene expression profiling revealed that keratinocytes from transgene-free hiPSC lines were more similar to normal human keratinocytes than those from transgene-residual hiPSC lines, which may be partly explained by reactivation of residual transgenes upon induction of keratinocyte differentiation. These results suggest that transgene-free hiPSC lines should be chosen for therapeutic purposes. ©AlphaMed Press.Entities:
Keywords: Differentiation; Human; Induced pluripotent stem cell; Keratinocyte; Transgene
Mesh:
Year: 2014 PMID: 25024429 PMCID: PMC4149296 DOI: 10.5966/sctm.2013-0179
Source DB: PubMed Journal: Stem Cells Transl Med ISSN: 2157-6564 Impact factor: 6.940